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ABSTRACT
Aims To examine the ability of different commonmeasures of cigarette dependence to predict smoking cessation during
pregnancy. Design Secondary analysis of data from a parallel-group randomized controlled trial of physical activity for
smoking cessation. The outcomes were biochemically validated smoking abstinence at 4weeks post-quit and end-of-
pregnancy. Setting Women identiﬁed as smokers in antenatal clinics in 13 hospital trusts predominantly in southern
England, who were recruited to a smoking cessation trial. Participants Of 789 pregnant smokers recruited, 784 were
included in the analysis.Measurements Using random-effect logistic regression models, we analysed the effects of base-
line measures of cigarette dependence, including numbers of cigarettes smoked daily, Fagerström Test of Cigarette Depen-
dence (FTCD) score, the two FTCD subscales of Heaviness of Smoking Index (HSI) and non-Heaviness of Smoking Index
(non-HSI), expired carbon monoxide (CO) level and urges to smoke (strength and frequency) on smoking cessation. Asso-
ciations were adjusted for signiﬁcant socio-demographic/health behaviour predictors and trial variables, and area under
the receiver operating characteristic (ROC) curve was used to determine the predictive ability of the model for each mea-
sure of dependence. Findings All the dependence variables predicted abstinence at 4weeks and end-of-pregnancy. At
4weeks, the adjusted odds ratio (OR) (95% conﬁdence interval) for a unit standard deviation increase in FTCD was
0.59 (0.47–0.74), expired CO=0.54 (0.41–0.71), number of cigarettes smoked per day 0.65 (0.51–0.84) and frequency
of urges to smoke 0.79 (0.63–0.98); at end-of-pregnancy they were: 0.60 (0.45–0.81), 0.55 (0.37–0.80), 0.70
(0.49–0.98) and 0.69 (0.51–0.94), respectively. HSI and non-HSI exhibited similar results to the full FTCD.
Conclusions Four common measures of dependence, including number of cigarettes smoked per day, scores for
Fagerström Test of Cigarette Dependence and frequency of urges and level of expired CO, all predicted smoking abstinence
in the short term during pregnancy and at end-of-pregnancy with very similar predictive validity.
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INTRODUCTION
Smoking in pregnancy is the main preventable cause of
poor birth outcomes, including miscarriage, stillbirth,
prematurity and low birth weight [1–6]. Smoking also pre-
sents immediate risks for the mother, including placental
abruption [7], as well as the long-term risks reported for
smokers in general. In high-income countries, the preva-
lence of smoking during pregnancy is estimated to be
between 10 and 26% [8–13]. It has been shown that
smoking cessation during pregnancy improves maternal
and fetal health and birth outcomes [14].
To target interventions for maternal smoking cessation
appropriately, there is a need to identify which
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characteristics of smokers promote or inhibit smoking ces-
sation during pregnancy [15,16]. A literature review [17]
revealed a wide range of socio-demographic, smoking and
psychological characteristics investigated as potential pre-
dictors of smoking cessation during pregnancy. Socio-
demographic factors that have been shown to predict
cessation significantly during pregnancy include maternal
age, being married or living with partner, primiparity and
higher socio-economic status (income, education, housing,
employment). Smoking-related variables that have been
found to predict cessation significantly in pregnancy in-
clude lower number of cigarettes smoked per day and if a
partner or house member smokes. Finally, psychological
variables that have been shown to predict cessation in
pregnancy include lower levels of depression, stress and
anxiety [17,18]. Other predictors of cessation include
higher self-efficacy for quitting, exposure to environmental
tobacco smoke, exposure to patient education methods,
greater perceived social support, stressful life events in early
pregnancy, ethnicity, family history of diabetes and no use
of marijuana before the pregnancy [19–22].
Cigarette dependence measures have been shown to be
valid in non-pregnant smokers [23–27], but little is
known about their validity for predicting smoking
cessation in pregnancy. For example, among pregnant
smokers the odds of cessation have been related inversely
to baseline cotinine level [24], and in another study [29]
scores for Fagerström Test of Cigarette Dependence
(FTCD), urges to smoke and withdrawal symptoms failed
to predict smoking status 2weeks following the quit date.
Therefore, in this study we examined the predictive valid-
ity of common measures of dependence on smoking cessa-
tion in pregnancy. As a demonstration of predictive
validity, we expect that higher scores of these measures
would be associated inversely with cessation. The most
widely used measure of cigarette dependence is the FTCD
[30–33], while the biochemical marker of expired carbon
monoxide (CO) [34,35] and urge to smoke [36,37] are
also used commonly to measure dependence. The
Heaviness of Smoking Index HSI [38], composed of two
items from the FTCD (time to first cigarette of the day
and number of cigarettes usually smoked per day), has
been shown to predict failure of quit attempts in non-
pregnant smokers in both population-based [24,37] and
clinical studies [27,31,32,39]. Therefore, we also
examined the HSI and non-HSI (comprised of the other
four items in the FTCD) as predictors of abstinence. Urges
to smoke have also been reported as significant predictors
of abstinence in non-pregnant smokers [37,40,41] but
have not been assessed in a study of long-term cessation
in pregnancy. Thus, this study examined potential ciga-
rette dependence related predictors of smoking cessation
at 4weeks post-quit and end-of-pregnancy in a rigorously
conducted large trial of a smoking cessation intervention
during pregnancy among women who attempted to quit.
It is important to identify dependence variables that
predict smoking abstinence during pregnancy so that we
can target interventions most effectively at women who
most need them and understand more clearly the response
to interventions among women with varying levels of
dependence.
The present study aimed to contribute to the evidence
for predictors of smoking cessation during pregnancy by
employing a large clinical sample that made a definite quit
attempt. This sample enabled a robust test of the predictive
ability of baseline measures of cigarette dependence when
controlling for a range of socio-demographic variables
through applying a strict criterion for abstinence, involving
continuous smoking from the quit date onwards,
supported by biochemical verification 4weeks after the
target quit date and at the end of pregnancy.
MATERIALS AND METHODS
Participants
This study is based on the secondary analysis of data from a
randomized controlled trial of a physical activity interven-
tion for smoking cessation in pregnancy [42]. Of the
8096 recorded as smokers at the first antenatal clinic visit
in 13 National Health Service hospitals in southern
England, a sample of 789 women who could be contacted
fulfilled the inclusion criteria and were willing to partici-
pate, were randomized, using random permuted blocks of
random size stratified by recruitment centre in a 1 : 1 ratio,
to either the physical activity group (n=394) or control.
Five women were excluded, two women were enrolled
twice in their second pregnancies (we removed their
second enrolment), two women were ineligible at their
baseline visit but had been randomized erroneously and
one woman withdrew consent before providing baseline
data. Seven hundred and eighty-four eligible participants
aged 16–50years, with 10–24weeks gestation, currently
smoking at least one cigarette daily, and prepared to quit
smoking 1week after enrolment, were included in this
analysis (Fig. 1).
Trial protocol
The full protocol for the trial, approved by theWandsworth
NHS Research Ethics Committee, is published elsewhere
[43]. All participants provided written informed consent.
At enrolment, participants were randomized to six sessions
of behavioural support alone (control) or this support plus
a physical activity (PA) intervention, combining 14 ses-
sions of supervised treadmill exercise and PA consultations.
The women were advised to be active for at least
10minutes at a time, progressing towards 30minutes of
activity on at least 5 days a week. All participants made a
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quit attempt; they began preparation for quitting at their
first treatment session, attempted to quit approximately
1week after this first session and attended a treatment
session on their quit day.
Baseline measures
The following demographic, psychological and smoking
characteristics available at baseline were considered for as-
sessment as potential predictors of smoking cessation: age,
ethnicity, body mass index (BMI), marital status, parity,
gestational age, gestational interval between baseline and
end of pregnancy, study centre, randomization groups
(physical activity versus control), alcohol consumption
[44], self-reports of moderate–vigorous-intensity physical
activity (MVPA) in the previous week [45], age at full-time
education, occupation, Edinburgh postnatal depression
scale (EPDS) [46] score, partner smoking status, number
of cigarettes smoked per day before pregnancy, number of
cigarettes smoked per day at baseline, smoking status in
previous pregnancy, FTCD score [30] (plus the scores for
the HSI and non-HSI components of the FTCD), expired
CO level [parts per million (p.p.m.)] [35] and weekly
smoking urges [36]. The FTCD (scored 0–10) consists of
six items: number of cigarettes smoked per day 10 or
less=0, 11–20=1, 21–30=2, 31 or more=3; time to
first cigarette of the day (60+ minutes=0, 31–60
minutes=1, 6–30 minutes=2, 0–5 minutes=3); diffi-
culty not smoking in no-smoking areas (no=0, yes=1);
which cigarette would the smoker most hate to give up
scored (‘first of the morning’=1, others=0); smoke more
frequently in first hours after waking (no=0, yes=1);
and smoke when ill in bed (no=0, yes=1). Higher FTCD
scores indicate greater cigarette dependence. The first two
FTCD items make up the HSI, scored 0–6 [38]. Weekly
smoking urges (scored 0–10) consists of the combined
ratings of strength and frequency of urges [36,37]. The
ratings of strength are: no urges=0, slight=1, moder-
ate=2, strong=3, very strong=4 and extremely
strong=5; and frequency: not at all = 0, a little of the
time=1, some of the time=2, a lot of the time=3, almost
all the time=4 and all the time=5. As well as the ‘com-
bined’ measure, we examined the frequency and strength
of urges measures separately as predictors of abstinence.
Figure 1 Numbers of participants who were enrolled into the study and included in the analysis
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Smoking cessation measures
The outcomes were self-reported continuous smoking ab-
stinence from quit date to 4weeks post-quit and from quit
date to end-of-pregnancy. Following guidelines,1 tempo-
rary, brief smoking lapses of up to five cigarettes (on up to
five occasions) were permitted [47]. Biochemical validation
of self-reports was undertaken at 4weeks post-quit and
end-of-pregnancy and concentration of either exhaled CO
(<8p.p.m.) or salivary cotinine (<10ng per millilitre)
was used to validate abstinence; if both measures were
available, both were required.
Statistical analysis
Baseline characteristics of the sample were summarized
using descriptive statistics. The main aim of the analysis
was to understand the association between measures of
cigarette dependence and smoking cessation outcomes.
In all the following random-effect logistic regression analy-
ses the dependent variables were smoking cessation at
4weeks after the quit day and at end-of-pregnancy. First,
we conducted analysis adjusted for the random effect of
study centre to explore the associations between cigarette
dependence baseline variables (i.e. scores for the FTCD
and the HSI and non-HSI components of the HSI, number
of cigarettes smoked per day, expired CO level and ratings
for urges to smoke) and the smoking cessation outcomes.
The standardized Z-scores of these variables were used to
facilitate the mutual comparison of their effect sizes. We
then identified baseline socio-demographic/health behav-
iour factors that were associated significantly with
smoking cessation by using random-effect logistic regres-
sion analyses. We conducted likelihood ratio tests to assess
the statistical significance. For the continuous variables in
the random-effect logistic regressionmodel, it was assumed
that the log odds of smoking cessation were related linearly
to the continuous predictor. To assess this assumption and
determine whether each variable would be best added to
the model as a continuous or as a categorical variable, we
used the likelihood ratio test (e.g. age at leaving full-time
education was divided into quintiles and the model fits
were compared when it was fitted as a categorical variable
or as a linear trend).
Next, we used a series of random-effect logistic regres-
sion models to examine the independent associations
between each measure of dependence and the cessation
outcomes, when adjusting for potential socio-demo-
graphic/health behaviour factors that were shown to be
associated significantly (P<0.05) with smoking cessation
in the univariate analysis and gestational interval between
baseline and end of pregnancy, while allowing for the
variability across the study centre and treatment effect.
We did not fit a model containing multiple measures of de-
pendence because the measures would be expected to be
correlated with each other, leading to potential
multicollinearity, and the intention of the analysis was to
assess whether all these measures predict smoking cessa-
tion outcomes, rather than assessing the independence of
their effects. We used adjusted odds ratios [(OR), 95% con-
fidence interval (CI)] and area under the receiver operating
characteristic (ROC) curve as a post-estimation measure of
model fit to determine which of the predictors provide
higher adjusted effect size and predictive validity. To exam-
ine whether the effect of the HSI and non-HSI is similar to
FTCD, we compared their adjusted results from the models.
For 149 (19%) of the participants at 4weeks post-quit
and 45 (5.7%) at end-of-pregnancy, smoking status was
not available and it was assumed that they are smoking
[47]. As a sensitivity analysis, to verify the results obtained
in the above analyses, we conducted multiple imputation
analyses, which assume instead that data are missing at
random. Missing smoking abstinence status was replaced
by imputed values using chained equations [48,49] of
logistic regression for smoking cessations at the two
follow-up times. The baseline variables of randomization
groups, age at leaving full-time education, married or
living with partner, women with partners who smoke,
number of cigarettes smoked daily before pregnancy, FTCD
score, any current alcohol use and self-reporting MVPA
>150minutes per week and study centre were used as
explanatory variables in the imputation models. Three
missing values in CO were also replaced by imputed values
using linear regression models in the chained equations.
We created 20 imputed data sets and conducted the same
analyses as above to explore the predictors of smoking
cessation in the imputed data sets. The imputation-specific
results of the predictors were combined using Rubin’s rules
[50]. All statistical analyses were conducted using Stata
version 12.
RESULTS
Baseline characteristics
A summary of the baseline characteristics and smoking
abstinence of the sample is provided in Table 1. Seven hun-
dred and eighty-four participants were included in the
analysis; 111 (14%) and 55 (7%) achieved continuous
abstinence at 4weeks and at the end of pregnancy, respec-
tively. The participants were, on average, aged 28years and
16weeks pregnant, the majority were married or living
with partner, Caucasian and primiparity. Before pregnancy
all participants were reasonably heavy smokers, smoking a
1West and colleagues’ [36] guideline for assessing smoking abstinence advises using self-report of smoking abstinence over the whole follow-up period
allowing up to ﬁve cigarettes in total, with biochemical veriﬁcation of abstinence, at least, at the end of the follow-up period.
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median of 20 cigarettes per day, and almost half had
smoked in a previous pregnancy. At baseline, they still
smoked a median of 10 cigarettes per day. At baseline, a
quarter reported drinking any alcohol, more than two-
thirds reported ≥150minutes weekly of moderate–
vigorous intensity physical activity. For the dependence
measures there was evidence of multi-collinearity, such
that the correlation coefficients between FTCD score and
number of cigarettes smoked per day, expired CO level
and ratings for urges to smoke were 0.411, 0.556 and
0.386, respectively (all at P<0.001).
Random-effect logistic analysis to explore the predictors
In the univariate regression analyses (see Table 3), the sig-
nificant cigarette dependence-related predictors of smoking
abstinence at both 4weeks and end-of-pregnancy were:
lower score for the FTCD and its two components (i.e. HSI
and non-HSI), lower number of cigarettes smoked daily,
lower expired CO level and lower score for urges to smoke
(for both ‘combined’ measure and for separate measures
for frequency and strength of urges). When we assessed
whether all the continuous independent variables were
fitted appropriately as linear effects in the logistic regres-
sion analyses, the likelihood ratio test suggested no
evidence of departure from linear effects.
Of the socio-demographic/health behaviour variables,
higher age at leaving full-time education and married or
living with partner were associated significantly with
smoking abstinence at both 4weeks and end-of-
pregnancy; self-reporting MVPA ≥150minutes per week
reached the 10% level of significance for end-of-pregnancy
abstinence and was significant at the 5% level for 4weeks,
gestational interval between baseline and end-of-
pregnancy approached significance at end-of-pregnancy
(see Table 2). Therefore we adjusted the effect of each ciga-
rette dependence-related predictor for these four variables
while also allowing for variability across the study centres
and treatment effect in the models (see Table 3).
Multiple random-effect logistic regression analyses for
each of the dependence measures
In multiple logistic regression analyses, each measure of
cigarette dependence remained as a significant predictor
of smoking abstinence at 4weeks. Adjusted OR (95% CI)
for a unit standard deviation increase in FTCD score was
0.59 (0.47–0.74), HSI 0.64 (0.51–0.79), non-HSI 0.64
(0.51–0.79), expired CO 0.54 (0.41–0.71), number of cig-
arettes smoked per day 0.65 (0.51–0.84) and frequency of
urges to smoke 0.79 (0.63–0.98); and at end-of-pregnancy
for FTCD 0.60 (0.45–0.81), HSI 0.65 (0.48–0.87), non-
HSI 0.65 (0.48–0.88), expired CO 0.55 (0.37–0.80), num-
ber of cigarettes smoked per day 0.70 (0.49–0.98) and
frequency of urges to smoke 0.69 (0.51–0.93). The com-
bined score of frequency and strength of urges to smoke
was also a significant predictor of abstinence at end-of-
pregnancy and approached significance at 4weeks (see
Table 3) while strength of urges to smoke did not predict
abstinence significantly at either time-point. In all cases,
higher levels of the measures of cigarette dependence were
associated with worse outcomes for abstinence. The values
Table 1 Baseline characteristics of the sample.
Variables
(n= 784)
Mean (SD)
Age (years) 27.5 (6.3)
Age at leaving full-time education (years)a 17.7 (2.9)
Weight (kg) 70.0 (15.0)
Body Mass Index 9 (kg/m)2b 26.1 (5.3)
Gestational age (weeks) 15.6 (3.3)
Gestational interval between baseline and
end-of-pregnancy (weeks)
23.3 (4.0)
Median (IQR)
Number of cigarettes smoked daily before
pregnancy
20 (12–20)
Number of cigarettes smoked per day at
baseline
10 (5–13
Fagerström Test of Cigarette Dependence score 4 (2–5)
Heaviness of Smoking Index scorec 2 (1–3)
Non-Heaviness of Smoking Index scored 2 (1–3)
Expired carbon monoxide (CO) level (p.p.m.)e 10 (6–14)
Urge to smoke scoref 6 (4–8)
Frequency of urge to smoke 3 (2–4)
Strength of urge to smoke 3 (2–4)
Self-reported of weekly MVPA (minutes) 210.0 (130–355)
No. (%)
Randomization group (physical activity) 391 (49.9)
Married or living with partner 451 (58)
Women with partners who smoke 511 (65.2)
Caucasiang 607 (77)
Professional/managerial occupation 99 (13)
Smoked in a previous pregnancy 379 (48)
Edinburgh Postnatal Depression Scale
score> 15
83 (10.6)
Self-reporting MVPA ≥ 150minutes/week 548 (69.9)
Primiparityh 420 (53.6)
Previous preterm birthi 129 (16.5)
Any current alcohol use 201 (25.6)
MVPA =moderate–vigorous intensity physical activity; IQR = interquartile
range; p.p.m. = parts per million. aFor 41 women, current age was consi-
dered as age at full-time education, as they were still in full-time education.
bFor three women, weight/body mass index (BMI) at their ﬁrst antenatal
booking visit was used as baseline weight/BMI, as it was not recorded for
them at baseline. cComposed of two Fagerström Test of Cigarette Depen-
dence items (i.e. time to ﬁrst cigarette of the day and number of cigarettes
usually smoked per day). dComprising four Fagerström Test of Cigarette De-
pendence items other than the two items of Heaviness of Smoking Index
(HIS). eCarbonmonoxide (CO) was not recorded for three participants. fUrge
to smoke score = frequency of urges + strength of urges. gRace or ethnic
group was self-reported and categorized according to standard UK census
categories. hPrimiparity was deﬁned as the ﬁrst-time pregnancy progressing
beyond 24weeks. iPrevious preterm birth was deﬁned as any previous preg-
nancy that lasted from 24 to 37weeks.
1660 Muhammad Riaz et al.
© 2016 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction Addiction, 111, 1656–1665
of area under the ROC curve for the model’s performance
showed that the predictive validity for all the dependence
measures was very similar (see Table 3).
Sensitivity analyses using multiple imputations
When we used multiple imputations as an alternative way
of dealing with missing outcomes data, the results for all
analyses were very similar. In particular, at end-of-
pregnancy the adjusted pooled OR (95% CI) for each asso-
ciation of the scores for FTCD and its two subscales (i.e. HSI
and non-HSI), expired CO level, number of cigarettes
smoked daily and the score for urges to smoke were: 0.58
(0.43–0.78), 0.61 (0.45–0.83), 0.64 (0.48–0.86), 0.53
(0.36–0.78), 0.68 (0.48–0.96) and 0.74 (0.55–0.98),
respectively.
DISCUSSION
Cigarette dependence, measured by the FTCD or by its HSI
or non-HSI components, expired CO level, cigarette con-
sumption or frequency of urges to smoke predicted
smoking cessation significantly at 4weeks post-quit during
pregnancy and at end-of-pregnancy.
The finding for FTCD predicting abstinence is consistent
for observations with non-pregnant smokers [23,27,31].
In our study, the predictive ability of the two components
of FTCD (i.e. HSI and non-HSI) and their effect sizes were
similar to FTCD; therefore, for economy, it might be better
to use the HSI, composed of only two items, for assessing
cigarette dependency in pregnant smokers. The finding
that lower expired CO levels predicted cessation is consis-
tent with the previous finding for saliva cotinine [28], an-
other biochemical marker of abstinence, and for CO levels
predicting abstinence at 6months postpartum [51], as well
as with findings for non-pregnant smokers [34]. The
finding for number of cigarettes smoked per day is consis-
tent with the results of lower number of cigarettes smoked
per day before pregnancy predicting cessation [18]. Thus,
number of cigarettes smoked per day or expired CO may
also be considered as valid brief predictors of smoking ces-
sation during pregnancy. The result for number of ciga-
rettes smoked per day is important in pregnancy, as
almost all women smokers who do not quit reduce their
smoking rate significantly when they find that they are
pregnant (by about 50% in this study). Thus, despite seri-
ous cutting down, the smoking rate still predicted absti-
nence. Urges to smoke have not been tested previously as
a predictor of smoking cessation during pregnancy, and
in this study frequency of urges to smoke showed signifi-
cant results at the two times and the combined score for
urges was also significant at end-of-pregnancy, which is
consistent with the results for studies in non-pregnant
populations [37,40,41].
Our review of the literature found that data for the ma-
jority of studies reporting predictors of smoking cessation in
pregnancy were from observational studies, and only a few
used data from clinical trials. Of the studies which used
Table 2 Random-effect logistic regression analysesa for socio-demographic/health behaviour predictors of smoking cessation at 4weeks
post-quit and the end-of-pregnancy (n=784)b.
Measures
4Weeks post-quit End of pregnancy
OR (95% CI) P-values OR (95% CI) P-values
Age (years)c 1.02 (0.99, 1.06) 0.172 1.02 (0.98, 1.06) 0.377
Age at leaving full-time education (years)c,d 1.07 (1.02, 1.14) 0.021 1.10 (1.01, 1.17) 0.022
Body Mass Index (kg/m2)c,e 1.00 (0.97, 1.04) 0.779 1.02 (0.97, 1.07) 0.475
Married or living with partner 2.01 (1.29, 3.12) 0.002 1.91 (1.04, 3.49) 0.036
Primiparityf 1.13 (0.75, 1.70) 0.549 1.20 (0.69, 2.10) 0.520
Women with partners who smoke 0.86 (0.54, 1.37) 0.529 0.96 (0.51, 1.83) 0.909
Edinburgh Postnatal Depression Scale score> 15 1.20 (0.63, 2.28) 0.573 0.84 (0.32, 2.17) 0.713
Self-reporting MVPA ≥ 150minutes/week 2.64 (1.53, 4.57) <0.001 1.77 (0.89, 3.50) 0.102
Alcohol use 1.17 (0.74, 1.83) 0.506 1.68 (0.94 2.99) 0.080
Gestational age (weeks) 1.00 (0.94, 1.06) 0.917 0.95 (0.87, 1.04) 0.248
Gestational interval between baseline and end of pregnancy 1.00 (0.95, 1.05) 0.923 1.08 (1.00, 1.16) 0.051
Living in a deprived area 0.75 (0.50, 1.14) 0.180 1.08 (0.61, 1.91) 0.788
Caucasiang 0.87 (0.54, 1.40) 0.565 1.05 (0.54, 2.050) 0.879
Occupation (managerial versus all others) 1.09 (0.60, 1.99) 0.765 1.37 (0.65, 2.91) 0.406
P-values shown in bold text represent signiﬁcant associations at P<0.05. MVPA =moderate–vigorous intensity physical activity; OR = odds ratio;
CI = conﬁdence interval. aAdjusted for the random effect of study centre. bFor 149 and 44 participants at 4 weeks post-quit and end of pregnancy, respectively,
the outcome was missing and it was assumed that they are smoking. cThe ORs reﬂect an effect of per unit change of the independent variable on smoking
cessation outcome. dFor 41 women, current age was considered as age at full-time education as they were still in full-time education. eFor three women,
weight/body mass index at their ﬁrst antenatal booking visit was used as baseline weight/body mass index as it was not recorded for them at baseline.
fPrimiparity was deﬁned as the ﬁrst-time time pregnancy progressing beyond 24weeks. gRace or ethnic group was self-reported and categorized according
to standard UK census categories.
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biochemically validated trial data, only two had a large
sample size. Power analysis was not conducted for this
study as it was based on secondary analysis, but our
study had a large sample size with biochemically vali-
dated continuous smoking cessation from quit day
through to end-of-pregnancy, with all participants mak-
ing a quit attempt. Thus, our study was conducted rigor-
ously, using a strict criterion for abstinence, and the use
of a strict abstinence criterion is important when testing
associations with factors promoting or undermining suc-
cess of a quit attempt. Weaker outcome measures, such
as point prevalence abstinence, are less useful, because
someone can have a full relapse to smoking on one or
more occasions and still be counted as abstinent, thus
blurring the distinction between predicting quit attempts
and quit success. The quit rate of 7% in this study was
lower than in many previous pregnancy trials, examining
predictors with less rigorous abstinence criteria, but was
similar to a study using comparable abstinence criteria
[28]. Our study had a large sample size with greater
power for the analyses compared with most previous
studies. We used careful multivariable analysis methods,
with an efficient sensitivity analysis for missing smoking
status using multiple imputations, which investigated ad-
justed associations of the measure of cigarettes depen-
dence with abstinence. Compared with most previous
studies, we included smokers with a wider range of levels
of cigarette dependence (with eligible women only
needing to be smoking at least one cigarette a day at base-
line); therefore, with regard to dependence, the findings are
likely to be applicable to pregnant smokers in general.
This study is potentially limited in terms of the repre-
sentativeness of the sample. First, the participants were re-
cruited predominantly in London, where the smoking rates
tend to be lower than the rest of the country. Secondly,
some of the women recorded as smokers at the antenatal
clinics could not be contacted; of those who were
contacted, some declined the offer of joining the study
and some were excluded due to the exclusion criteria of
the trial, although there were few exclusion criteria [43].
We were unable to compare the characteristics of those
whowere recruited with those whowere not.We recruited
women who mainly reported being physically active at
baseline and who, therefore, might be more motivated to
quit than less active women; this is likely to be because
active women were attracted to a trial promoting physical
activity in a health-care setting. Ten per cent of women
recorded as smokers at the first antenatal booking visit
were recruited, which was the target recruitment rate
and is similar to rates for other large UK trials of smoking
cessation in pregnancy [52,53]. Quit rates were lower than
for pregnancy trials with less rigorous outcome measures,
but were similar to those for studies using comparable out-
comes [4]. The women were generally representative of
women who smoke [54], and the findings are likely to be
generalizable to primary and secondary care settings.
We have reported elsewhere [42] that there was no sig-
nificant effect of the multi-session treatment on smoking
cessation; however, we adjusted the results for the treat-
ment effect in this study. The intervention group had to
change two behaviours (i.e. smoking and physical activity)
simultaneously, while also coping with being pregnant and
attending multiple treatment sessions; this could have a
negative impact on cessation, which may then have an ef-
fect on the predictive ability of the dependency measures.
Although this study considered a broad range of variables
that might have an impact upon smoking cessation there
are other variables which we did not include, which have
been found to predict cessation in pregnancy and which
might be important, such as whether the pregnancy is
planned, exposure to environmental tobacco smoke, expo-
sure to patient education methods, perceived social sup-
port, stressful life events in early pregnancy, use of illicit
substances before pregnancy, motivation to quit and
nausea during pregnancy [19–22].
These findings are important for public health policy, as
they highlight the importance of cigarette dependence for
smoking cessation in pregnancy, demonstrate thatmultiple
facets of dependence are likely to play a role in cessation
and identify dependence measures that are clinically quick
to administer to tailor cessation treatments. As cigarette
dependence appears to be a predictor of smoking cessation
during pregnancy, interventions need to focus upon
supporting quit attempts among those who seek treatment
and are more highly dependent (e.g. through helping
women avoid and manage urges to smoke). Assessment
of dependence during pregnancy is crucial, so that appro-
priate support is provided to those women who are most
dependent, with increased intensity of support, including
higher doses and longer durations of nicotine replacement,
for those with higher dependence [52]. The finding that
the non-HSI part of the FTCD was predictive of abstinence
suggests that, besides the commonly used HSI, the non-HSI
may also be important.
CONCLUSION
These findings show that, in a trial of a smoking cessation
intervention, higher levels of several common baseline
measures of cigarette dependence, including number of
cigarettes smoked per day, scores for FTCD and frequency
of urges and level of expired CO, all predicted smoking absti-
nence in the short term during pregnancy and at end-of-
pregnancy with very similar predictive validity. In research
studies or in clinical settings, it may be most practicable to
include either of the brief components of FTCD (i.e. HSI and
non-HSI) rather than the full FTCD. Studies are needed to
investigate these and other measures of cigarette
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dependence as predictors of smoking abstinence in further
trials and in population-based studies.
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